Literature DB >> 2866337

Transient idiopathic hyperammonaemia in adults.

A J Watson, T Chambers, J E Karp, V R Risch, W G Walker, S W Brusilow.   

Abstract

Transient severe hyperammonaemia developed in the absence of serious liver dysfunction in three patients being treated for acute leukaemia. The onset of the biochemical disturbance was abrupt and led rapidly to acute encephalopathy, fatal in two cases. In the third patient, prompt initiation of aggressive haemodialysis and intravenous sodium benzoate and sodium phenylacetate infusion successfully controlled plasma ammonium levels until they spontaneously resolved. The cause of the disorder remains to be determined, but urinary nitrogen partition studies suggest temporary impairment of ureagenesis in a catabolic setting as a major pathophysiological feature of this disorder. The absence of liver disease, the normal mitochondrial ultrastructure seen in two cases, and the plasma aminoacid profiles observed serve to distinguish this disorder from others such as Reye's syndrome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866337     DOI: 10.1016/s0140-6736(85)91554-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

Review 1.  Treatment of acute liver failure.

Authors:  K H Boeker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Astrocytes protect neurons from ammonia toxicity.

Authors:  K V Rama Rao; K S Panickar; A R Jayakumar; M D Norenberg
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

3.  Hyperammonaemic coma in ureterosigmoid urinary diversion.

Authors:  R M Oliver; S Talbot; G V Raman
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

Review 4.  Acute metabolic encephalopathy: a review of causes, mechanisms and treatment.

Authors:  R Surtees; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 5.  Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.

Authors:  Saul W Brusilow; Raymond C Koehler; Richard J Traystman; Arthur J L Cooper
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

6.  Ammonia-induced astrocyte swelling in primary culture.

Authors:  M D Norenberg; L Baker; L O Norenberg; J Blicharska; J H Bruce-Gregorios; J T Neary
Journal:  Neurochem Res       Date:  1991-07       Impact factor: 3.996

7.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

8.  Menstrual cycle and gonadal steroid effects on symptomatic hyperammonaemia of urea-cycle-based and idiopathic aetiologies.

Authors:  W W Grody; R J Chang; N M Panagiotis; D Matz; S D Cederbaum
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium report.

Authors:  Susan M Chang; John G Kuhn; H Ian Robins; S Clifford Schold; Alexander M Spence; Mitchel S Berger; Minesh P Mehta; Ian Pollack; Mark Gilbert; Michael D Prados
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

10.  A novel bioreactor for the stable growth of Ureaplasma parvum and Ureaplasma urealyticum.

Authors:  Derek Fleming; Melissa Karau; Robin Patel
Journal:  J Microbiol Methods       Date:  2020-12-30       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.